α2 Macroglobulin and the risk of Alzheimer’s disease
Our data support an association between the A2M gene and AD. This association is less pronounced, however, in our cohort than in the previously reported sample of sibpairs.
Our data support an association between the A2M gene and AD. This association is less pronounced, however, in our cohort than in the previously reported sample of sibpairs.
Solanezumab at a dose of 400 mg administered every 4 weeks in patients with mild Alzheimer's disease did not significantly affect cognitive decline. (Funded by Eli Lilly; EXPEDI...
Abstract Introduction To compare dementia incidence of African‐American and Yoruba cohorts aged ≥70 years enrolled in 1992 and 2001. Methods African‐Americans residing in Indian...
h-index: Number of publications with at least h citations each.